21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Enteric combination therapy
#10802Medical compositions with Omega-3 containing excipients
#10803METHODS OF IMPROVING REPRODUCTIVE AND RESPIRATORY HEALTH
#10804THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#10805Substituted phenyl boronic acid containing polymers and methods of use
#10806THERAPEUTIC TARGETS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#10807PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#10808ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT
#10809CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE
#10810COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN
#10811COMBINATION THERAPY FOR TREATING CANCER
#10812Heterocyclic compounds, preparation methods and uses thereof
#10813Benzamide compounds
#10814Bio-Based Medicines and Methods of Increasing Patient Compliance
#10815MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE
#10816INHIBITION OF BETA-2 NICOTINIC ACETYLCHOLINE RECEPTORS TO TREAT ALZHEIMER'S DISEASE PATHOLOGY
#10817METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME
#10818GPR40 AGONISTS
#10819TELMISARTAN FOR THE TREATMENT OF HYPERTENSION IN DOGS
#10820COMPOSITIONS AND METHODS FOR THE TREATMENT AND MITIGATION OF ALCOHOL-INDUCED SKIN FLUSHING
#10821COMPOUNDS FOR USE IN ANTI-CANCER IMMUNOTHERAPY
#10822Composition for Prevention, Amelioration, or Treatment of Cancer
#10823METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE
#10824CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLS
#10825COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS
#10826ORALLY ADMINISTRABLE COMPOSITION
#10827Stable silk protein fragment compositions
#10828POUCHED PRODUCTS WITH HEAT SEALABLE BINDER
#10829METHODS AND COMPOSITIONS FOR TREATING MELANOMA
#10830Compositions and processes for targeted delivery, expression and modulation of coding ribonucleic acids in tissue
#10831METHODS AND COMPOSITIONS OF SHORT SMALL HAIRPIN RNAS AND MICRORNAS FOR WOUND HEALING
#10832MODULATORS OF TELOMERE DISEASE
#10833Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
#10834Treatment of allergic diseases with chimeric protein
#10835Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A
#10836COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF AUTOIMMUNE AND INFLAMMATORY DISEASES
#10837B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION INHIBITING PEPTIDOMIMETICS
#10838Compositions and methods for treating CNS disorders
#10839METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR CONDITIONS RELATED TO THE SAME
#10840CD73 inhibitors
#10841Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases
#10842PCSK9 INHIBITORS AND METHODS OF USE THEREOF
#10843Compositions and methods for viral sensitization
#10844JAK1 SELECTIVE KINASE INHIBITOR
#10845Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
#10846METHOD OF TREATMENT BY RADIOTHERAPY
#10847COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION
#10848Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents
#10849TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES
#10850DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES
#10851Human antibodies to PCSK9 for use in methods of treating particular groups of subjects
#10852COMBINATION GMCI AND ATRI CANCER TREATMENT
#10853COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#10854Sequence specific antimicrobials
#10855Sequence specific antimicrobials
#10856Sequence specific antimicrobials
#10857COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#10858Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral Infections
#10859METHODS OF ENHANCING THE POTENCY OF INCRETIN-BASED DRUGS IN SUBJECTS IN NEED THEREOF
#10860METHODS FOR IMPROVING TREATMENT OF EQUINE COLIC BY ADMINISTRATION OF A SYNTHETIC BIOENSEMBLE OR PURIFIED STRAINS THEREOF
#10861QUADRI-POSITIVE STROMAL CELL (QPSC) POPULATION FOR SUPERIOR CELL PROTECTION AND IMMUNOMODULATION
#10862Therapeutic pharmaceutical composition for cancer including miRNA
#10863COMBINATION THERAPIES FOR CANCER TREATMENT
#10864NOVEL USE OF PYRROLO-PYRIDINE DERIVATIVE COMPOUND FOR PREVENTION AND/OR TREATMENT OF CANCER
#10865COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
#10866FGFR INHIBITORS FOR THE TREATMENT OF CANCER
#10867COMPOSITIONS AND METHODS COMPRISING ENDOTHELIN A RECEPTOR ANTAGONISTS AND ANDROGEN THERAPIES
#10868Treatment of chronic cough, breathlessness and dyspnea
#10869ARYLQUINOZILINE DERIVATIVES AS ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
#10870TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS
#10871METHODS OF TREATING DISEASES CHARACTERISED BY VASOCONSTRICTION
#10872DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF
#10873COMBINED MAPK AND NAMPT INHIBITION FOR TREATMENT OF NEURON DEGENERATION
#10874PI3K/LYN-ACLY Signaling Inhibition
#10875ANTIBIOTIC CANNABINOID-TERPENE FORMULATIONS
#10876METHODS OF TREATING CYTOKINE RELEASE SYNDROME
#10877METHOD AND COMPOSITION FOR TREATING OSTEOARTHRITIS
#10878METHODS OF TREATMENT WITH DEUTERATED ANALOGS OF D-SERINE
#10879TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS
#10880Sensorineural Hair Cell Differentiation
#10881Ketone supplements-evoked effect on absence epilepsy by co-administration of uridine
#10882METHODS AND FORMULATIONS FOR TREATING VISION DISORDERS
#10883TABLET AND METHOD FOR PRODUCING TABLET
#10884Synthetic progestogens and pharmaceutical compositions comprising the same
#10885Treatment of hip pain with sustained-release liposomal anesthetic compositions
#10886Treatment of hip pain with sustained-release liposomal anesthetic compositions
#10887INJECTABLE POLYMER NANOPARTICLE COMPOSITIONS OF ANTITHROMBOTIC AGENTS AND METHODS THEREOF
#10888METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
#10889METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#10890RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION
#10891MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS
#10892DENDRITIC CELL IMMUNOTHERAPY
#10893CROSSLINKED POLYMER OF FUNCTIONALIZED HYALURONIC ACID AND ITS USE IN THE TREATMENT OF INFLAMMATORY STATES
#10894Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells
#10895Bruton's Tyrosine Kinase as Anti-Cancer Drug Target
#10896COMBINATION THERAPY OF MULTIPLE SCLEROSIS COMPRISING A CD20 LIGAND
#10897Immunomodulatory antibodies
#10898ANTI-TIE2 ANTIBODY AND USE THEREOF
#10899MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES
#10900Peptides and combination of peptides for use in immunotherapy against various tumors
#10901COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#10902SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES
#10903SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITY
#10904SUBSTITUTED HETEROCYCLES AS CYCLIC TREX1 INHIBITORS
#10905Inhibitors of Bruton's Tyrosine Kinase
#10906MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY
#10907GHRELIN O-ACYLTRANSFERASE INHIBITORS
#10908Metabolites of GLP1R agonists
#10909Oxopiperazine derivatives
#10910SUBSTITUTED (PIPERIDIN-1-YL)ARYL ANALOGUES FOR MODULATING AVIL ACTIVITY
#10911CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION
#10912CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
#10913Surgical system and methods of use
#10914INTRANASAL ADMINISTRATION OF ADENO-ASSOCIATED VIRUS TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
#10915Use of fructose in preparing drug for treating ischemic injury
#10916Pharmaceutical compositions comprising meloxicam
#10917Methods of cancer treatment using activated t cells
#10918TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS
#10919METHODS FOR TREATING BREAST AND OTHER CANCERS BY TARGETING ARGININOSUCCINATE SYNTHETASE 1-DEFICIENCY
#10920Fungal iron acquisition inhibitors and uses thereof
#10921COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#10922METHODS FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C
#10923Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
#10924COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF
#10925Method of Treatment
#10926TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#10927METHODS FOR TREATING HETEROTOPIC OSSIFICATION
#10928Inhibitors of IAP
#10929GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER
#10930PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
#10931METHODS FOR THE TREATMENT AND PROGNOSIS OF CANCER
#10932Treatments of prostate cancer
#10933Compositions and products for infectious or inflammatory diseases or conditions
#10934Mito-magnolol compounds and methods of synthesis and use thereof
#10935UVEAL MELANOMA TREATMENT
#10936PHARMACEUTICAL COMBINATION
#10937COMPOSITIONS AND METHODS FOR TREATING CANCER WITH NUCLEOSIDE-METABOLISM MODULATORS
#10938Methods and Compositions for Treating Cancer
#10939METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION
#10940Treatment of cancer utilizing an identified adenosine fingerprint
#10941Methods for Objective Assessment of Memory, Early Detection of Risk for Alzheimer's Disease, Matching Individuals With Treatments, Monitoring Response to Treatment, and New Methods of Use for Drugs
#10942QUINOLINE DERIVATIVES FOR TREATMENT OF HEAD AND NECK CANCER
#10943QUINOLINE DERIVATIVE USED FOR SOFT TISSUE SARCOMA COMBINATION THERAPY
#10944METHODS FOR TREATING PTEN-MUTANT TUMORS
#10945ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
#10946COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES
#10947Injectable psychoactive alkaloid composition and preparation thereof
#10948PREVENTING AND TREATING MALARIA
#10949PYRROLE AMIDE COMPOUND AND USE THEREOF
#10950LYMPH DIRECTING PRODRUGS
#10951METHOD OF TREATING CANCER BY ADMINISTERING AN EPIGALLOCATECHIN GALLATE COMBINED WITH TYROSINE KINASE INHIBITOR
#10952PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#10953METHODS FOR TREATING DISORDERS ASSOCIATED WITH SLEEP SPINDLE DEFICITS
#10954METHODS OF TREATING GASTROINTESTINAL CANCERS AND TUMORS THEREOF USING COMBINATION THERAPY
#10955Cannabinoid prodrug compounds
#10956COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE
#10957Stable aqueous capsaicin injectable formulations and medical uses thereof
#10958COMPOSITIONS AND METHODS FOR POTENTIATING DERIVATIVES OF 4-AMINOPHENOLS
#10959Maximizing Distribution and Minimizing Washout of Injectates in Bone and Method for Enhanced Aspirate Extraction
#10960COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#10961PRODUCTS OF MANUFACTURE AND METHODS FOR TRANSDERMAL DELIVERY OF PHARMACEUTICALS, ELECTROLYTES, AND NUTRICEUTICALS
#10962Pain Relieving Spray
#10963Water soluble compositions and methods of making the same
#10964COMPOSITIONS AND IMPLANTABLE DEVICES
#10965GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM
#10966Dirofilaria volatile organic compound signatures and uses thereof
#10967EXTRACELLULAR VESICLES DERIVED FROM ACTIVATED CAR-T CELLS
#10968COMBINATION OF HER2 ANTIBODIES
#10969ANTI-CD20 COMBINATIONS FOR TREATING TUMORS
#10970COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#10971ANTI-CD137 MOLECULES AND USE THEREOF
#10972ANTIBODIES AGAINST HUMAN CD38
#10973Anti-NPR1 antibodies and uses thereof
#10974COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS
#10975Combination Therapy for the Treatment of Cancer
#10976USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE
#10977CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF USE
#10978Antibody molecules and uses thereof
#10979Compositions and methods for the removal of biofilms
#10980Ha binding agents
#10981Synthetic immune receptors and methods of use thereof
#10982TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9
#10983ARGINASE INHIBITORS AND METHODS OF USE THEREOF
#10984Orally Active Melanocortin Receptor-4 Compounds
#10985HIGH-DENSITY AND SHORT-CHAIN PEG MODIFIED NANO-SIZED CARRIERS AND THEIR USES
#10986METHODS FOR REDUCING TOXICITY OF A CHEMOTHERAPEUTIC DRUG
#10987Method of treating, reducing, or alleviating a medical condition in a patient
#10988INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY
#10989CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS
#10990DEPOLYMERASE CAPABLE OF DEGRADING EXTRACELLULAR POLYMERIC SUBSTANCES OF KLEBSIELLA PNEUMONIAE
#10991SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF
#10992Therapeutic uses of dulaglutide
#10993COMPOSITIONS AND METHODS OF USING SENECA VALLEY VIRUS (SVV) FOR TREATING CANCER
#10994CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
#10995Therapeutic pharmaceutical composition for cancer including miRNA
#10996METHODS AND COMPOSITIONS FOR TREATING CANCER
#10997COMBINATIONAL THERAPIES FOR TREATMENT OF CANCER COMPRISING A BACTERIOCHLOROPHYLL DERIVATIVE
#10998JAK inhibitor with a vitamin D analog for treatment of skin diseases
#10999ANTIFUNGAL AGENTS USED IN COMBINATION
#11000NON-IRRITATING TESTOSTERONE EMULSIONS
#11001METHODS FOR TREATING GI TRACT DISORDERS
#11002METHODS FOR PREVENTING TOXICITY OF PLATINUM DRUGS
#110038-SUBSTITUTED ARYL VINYL XANTHINE DERIVATIVES AND USES THEREOF
#11004TREATMENT OF CANCER
#11005TREATMENT OF CANCER
#11006TREATMENT FOR RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR Ɣ (RORƔ)-DEPENDENT CANCERS
#11007METHODS OF TREATING DEPRESSION WITH VORTIOXETINE
#11008Compositions For Affecting Weight Loss
#11009TREATMENT OF H-RAS-DRIVEN TUMORS
#11010NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF KIDNEY DISEASES
#11011USE OF PRIDOPIDINE FOR THE TREATMENT OF FRAGILE X SYNDROME
#11012Antitumor composition
#11013METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES
#11014COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS
#11015Salts of selective estrogen receptor degraders
#11016ADMINISTRATION OF BERBERINE METABOLITES
#11017ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF
#11018Small molecule inhibitors of GPCR GPR68 and related receptors for treating cancer, glioblastoma, and other indications
#11019COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS
#11020DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM
#11021CANNABIS COMPOSITION
#11022CANNABINOID COMPOSITIONS AND METHODS OF USING
#11023Benzonatate modified release solid tablets and capsules
#11024PROTEIN SUBSTITUTE AMINO ACID COMPOSITIONS AND PRODUCTS, AND OTHER FOOD AND BEVERAGE PRODUCTS
#11025DYE COMPOSITION FOR MARKING ORGANIC TISSUE WITH ANAESTHETIC AND METHOD FOR APPLYING SAME
#11026Pharmaceutical composition
#11027METHODS OF TREATING MENTAL DISORDERS
#11028Methods of treatment of temozolomide-resistant glioma using coenzyme Q10
#11029CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#11030TREATMENT OF HIDRADENITIS SUPPURATIVA WITH TAPINAROF COMPOSITIONS
#11031TUMOR MICROBIOME SIGNATURE AND THERAPEUTIC USE OF FECAL MICROBIOTA TRANSPLANTATION ON PANCREATIC CANCER PATIENTS
#11032MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#11033METHOD AND KIT FOR DETECTING RISK OF COLORECTAL CANCER
#11034METHODS AND COMPOSITIONS FOR DIAGNOSIS AND MANAGEMENT OF NEURODEGERATIVE DISEASES
#11035REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#11036Anti-SIRP α antibodies
#11037Rank Pathway Inhibitors in Combination with CDK Inhibitors
#11038Anti-axl antagonistic antibodies
#11039Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector
#11040ANTI-PD-1 ANTIBODIES AND USES THEREOF
#11041ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER
#11042Methods for Treating Osteogenesis Imperfecta
#11043Monoclonal Antibodies to ELTD1 and Uses Thereof
#11044CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL
#11045Immunotherapy against several tumors including lung cancer
#11046SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
#11047AZAZINOINDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#11048DIHYDROPYRIMIDINE COMPOUND AND APPLICATION THEREOF AS DRUG
#11049Novel compounds and methods of use treating fructose-related disorders or diseases
#11050NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#11051HETEROARYL(HETEROCYCLYL)METHANOL COMPOUNDS USEFUL IN THE TREATMENT OF HYPERGLYCAEMIA
#11052Compositions and methods for adhesion to surfaces
#11053MICRONEEDLE ARRAYS FOR CANCER THERAPY APPLICATIONS
#11054HYDROGEL FOR IN-VIVO RELEASE OF MEDICATION
#11055Peptide-linked drug delivery system
#11056AGENT TARGETING DOUBLE-MEMBRANE ORGANELLE DNA
#11057METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS
#11058METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY
#11059COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS AND/OR TREATING IMMUNODEFICIENCY VIRUS INFECTION
#11060Methods and compositions for treating coronavirus infections
#11061SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN
#11062Method of treating cancer with an immune checkpoint inhibitor in combination with another therapeutic agent
#11063METHODS OF TREATING A TRAUMATIC BRAIN INJURY
#11064Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
#11065METHOD OF TREATING AND PREVENTING BONE AND JOINT INFECTIONS
#11066COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
#11067S-NITROSOGLUTATHIONE (GSNO) AND GSNO REDUCATASE INHIBITORS FOR USE IN THERAPY
#11068Composition for use in the treatment of major depressive disorder
#11069COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY
#11070Methods and compositions for modulating angiogenesis and vasculogenesis
#11071Methods and compositions for treating heart conditions
#11072Compositions of nitrates and methods of use thereof
#11073NOVEL THERAPEUTIC AGENT FOR GASTROINTESTINAL CANCER AND METHOD FOR SCREENING FOR THE SAME
#11074Methods for treating and Pharmaceutical compositions
#11075INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
#11076PHARMACEUTICAL COMPOSITIONS
#11077Combinations including ABX196 for the treatment of cancer
#11078COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
#11079COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#11080COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#11081QUINOLINE DERIVATIVE USED FOR COMBINATION TREATMENT OF SMALL CELL LUNG CANCER
#11082METHOD OF TREATING A SKIN CONDITION
#11083Compositions and methods of treating PIK3CA helical domain mutant cancers
#11084CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
#11085Pharmaceutical compositions comprising statins and hyaluronic acid derivatives
#11086USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#11087Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer
#11088COMPOSITIONS, METHODS AND USES FOR TARGETING C-TERMINAL BINDING PROTEIN (CtBP) IN TRAUMATIC BRAIN INJURY
#11089LIPID PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
#11090Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement
#11091COATINGS FOR GASTRIC RESIDENCE DOSAGE FORMS
#11092DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
#11093Synthetic progestogens and pharmaceutical compositions comprising the same
#11094METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF
#11095PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS
#11096Effervescent composition and method of making it
#11097Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms
#11098TUMOR CELL-DERIVED MICROVESICLES
#11099CD20 BINDING SINGLE DOMAIN ANTIBODIES
#11100HUMAN ANTIBODIES THAT BIND RET AND METHODS OF USE THEREOF